B. J. Scheessele
Chief Commercial Officer @Humacyte
Signup · Get unlimited contacts
WORK HISTORY
Chief Commercial Officer @Humacyte
Durham, NC, US
Led the creation of the commercial function (Market Access, HEOR, Marketing, and Sales) plus all cross-company capabilities for the U.S. launch of a new to the world, regenerative medicine vascular surgery product.• Developed a health economic, Budget Impact Model and submitted for NTAP incremental reimbursement with CMS.• Revamped all corporate branding and created new product branding and messaging for the Symvess™ launch including integration into PR and IR functions.• Quantified market positioning and segmentation plus identified hospital and military sales targets through a grounds up analytical data build.• Recruited and trained a direct sales team, sales management, and customer service teams for the product launch.
EDUCATION
Duke University
BSE, Biomedical Engineering and Economics
Duke University - The Fuqua School of Business
MBA, Finance
SKILLS
ABOUT B. J. SCHEESSELE
Commercial leader and growth catalyst with medical device and biotech experience creating and growing businesses through building and leading high performing teams while leveraging commercial analytics to drive market exceeding top and bottom-line results in concert with both private and public company boards. Key Accomplishments- Led the creation of the commercial function plus all cross-company capabilities as Chief Commercial Officer for the launch of Humacyte\'s new to the world, regenerative medicine vascular surgery product- Spearheaded the market re-entry for Sientra’s U.S. breast implant business as Vice-President Marketing by building a marketing team and a go-to-market plan, resulting in a $115M public offering of common stock- Turned around the $175M LifeCell U.S. general surgery business as Vice-President North America Marketing, delivering growth and beating the revenue budget for the first time in 4 years- Overachieved revenue performance by 5% realizing a 25% CAGR and also delivered EBITDA 10% ahead of plan and 30% CAGR as Country Manager of the $7M LifeCell Canadian business over the course of 3 years- Led NA Product Marketing to create and launch a new tissue perfusion diagnostic business and grew the LifeCell SPY franchise to $26M in 30 months- Overachieved the revenue budget for the $150M LifeCell U.S. plastic surgery business in back-to-back years while averaging 20% growth- Established the global launch cadence for LifeCell as head of WW Strategic Marketing and implemented the European commercialization plan in coordination with the regulatory, clinical, and reimbursement teams.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.